FXN and Cerebellar atrophy: Interestingly, impaired maturation of Frataxin was also reported in patients affected by mutations in the catalytic PMPCB subunit of MPP who present neurological regression and ataxia with basal ganglia lesions and cerebellar atrophy (Vögtle et al., 2018; Brunetti et al., 2021).